| Application no. and date | 12714163.8 (espacenet) (Federated) (European Patent Register), 20120330 | | Patent/reg. no. and date | DK/EP 2694037, 20161012 | | Publication date | 20140212 | | Priority no. and date | US 201161470747 P, 20110401, US 201161545835 P, 20111011 | | EP pub. no. and date |
EP 2694037 20140212 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/154416 | | Inventor | RANE, Supriya, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936-1080, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/137 (2006.01) , A61K 31/661 (2006.01) , A61K 9/16 (2006.01) , A61K 9/20 (2006.01) , A61K 9/48 (2006.01) , A61P 37/06 (2006.01) | | Title | Formuleringer omfattende 2-amino-2-[2-(4-octylphenyl)ethyl]propan-1,3-diol | | Int. application no. | US2012031340 | | Int. publication no. | WO2012135561 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
